Scarica l'app Stockscreener
0.3722
5.96%
-0.0236
Dopo l'orario di chiusura:
.38
0.0078
+2.10%
Precedente Chiudi:
$0.3958
Aprire:
$0.382
Volume 24 ore:
91,749
Relative Volume:
0.01
Capitalizzazione di mercato:
$9.48M
Reddito:
$357.90K
Utile/perdita netta:
$-11.06M
Rapporto P/E:
-0.3323
EPS:
-1.1201
Flusso di cassa netto:
$-11.90M
1 W Prestazione:
-1.01%
1M Prestazione:
-8.10%
6M Prestazione:
-68.46%
1 anno Prestazione:
-75.51%
Intervallo 1D:
$0.365
$0.394
Intervallo di 1 settimana:
$0.365
$0.4142
Portata 52W:
$0.1593
$1.89
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Nome
Biorestorative Therapies Inc
Settore
Industria
Telefono
(631) 760-8100
Indirizzo
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.3722 | 10.08M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie
Here's why Biorestorative Therapies (BRTX) looks ripe for bottom fishing - MSN
BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. - marketscreener.com
Enterprise value to EBITDA forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to earnings forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to earnings forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
BioRestorative (NASDAQ:BRTX) Gains Penny Stock Attention - Kalkine Media
Enterprise value to revenue forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Enterprise value to revenue forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
Price to book forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to sales forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
Price to book forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
BioRestorative Therapies, Inc. Actuals & Estimates (NASDAQ:BRTX) - TradingView
BRTX Forecast — Price Target — Prediction for 2027 - TradingView
BioRestorative Therapies, Inc. Actuals & Estimates (DUS:9OF) - TradingView
9OF Forecast — Price Target — Prediction for 2027 - TradingView
A3C9XF Forecast — Price Target — Prediction for 2027 - TradingView
BioRestorative Therapies Announces Completion of BRTX-100 Manufacturing for Phase 2 Clinical Trial - Quiver Quantitative
BioRestorative finishes BRTX-100 Phase 2 supply in-house - Stock Titan
BioRestorative Therapies Inc (BRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BRTX News | BIORESTORATIVE THERAPIES INC (NASDAQ:BRTX) - ChartMill
Biorestorative Therapies Company Profile & Introduction - Moomoo
Director Mika Grasso files initial Form 3 at BioRestorative (BRTX) - Stock Titan
BioRestorative Therapies (NASDAQ: BRTX) director Dhaliwal files clean Form 3 - Stock Titan
BioRestorative Therapies Inc (BRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth - The Manila Times
BioRestorative Therapies Appoints Zachary Smith as Vice President of Biocosmeceuticals Division - Quiver Quantitative
BioRestorative Therapies Inc (BRTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioRestorative Therapies Inc (BRTX) Institutional Confidence - TradingKey
BioRestorative Therapies Inc (BRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioRestorative Therapies Inc (BRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioRestorative Therapies (BRTX) director Katharyn Field files initial Form 3 - Stock Titan
BioRestorative Therapies Inc - TradingKey
BioRestorative Therapies Inc (BRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Discontinued operations of BioRestorative Therapies, Inc. – DUS:9OF - TradingView
Long term debt to total equity ratio of BioRestorative Therapies, Inc. – DUS:9OF - TradingView
BioRestorative Therapies, Inc. Cash Flow – DUS:9OF - TradingView
BioRestorative Therapies, Inc. Revenue Breakdown – DUS:9OF - TradingView
BioRestorative Therapies, Inc. Enters Revolving Credit Agreement with Bowery Group LLC – 12% Interest, NASDAQ: BRTX – Minichart - Minichart
BioRestorative Revamps Board Following New Loan Agreement - TipRanks
BioRestorative Therapies Finalizes Executive Agreement with R&D VP - TipRanks
BioRestorative Therapies enters $1 million revolving loan and appoints new directors - Investing.com Nigeria
BioRestorative (NASDAQ: BRTX) sets 3-year deal with R&D leader Silva - Stock Titan
BioRestorative Therapies, Inc. Enters Into $1,000,000 Revolving Loan Agreement With Bowery Group LLC - marketscreener.com
BioRestorative Therapies (NASDAQ: BRTX) adds $1M revolver and installs lender-backed directors - Stock Titan
BRTX Q1 2026 Earnings: Narrowed Loss Beats Estimates as Cash Management ContinuesEarnings Season Outlook - newsline.com
BioRestorative Therapies Inc. (BRTX) Q1 2026 Earnings: Narrowing Losses Drive Strong Stock SurgeRevenue Miss Report - newsline.com
BRTX Stock Price, Quote & Chart | BIORESTORATIVE THERAPIES INC (NASDAQ:BRTX) - ChartMill
BioRestorative Therapies Executive Employment Agreement with Lance Alstodt: Key Terms, Compensation, and Severance Details - Minichart
BioRestorative Therapies Extends Executive Leadership Employment Agreements - TipRanks
BioRestorative Therapies extends employment agreements for Lance Alstodt and Robert Kristal - TradingView
Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):